Taro Pharmaceutical
TARO
#4649
Rank
NZ$2.87 B
Marketcap
$76.53
Share price
0.00%
Change (1 day)
17.60%
Change (1 year)

EPS for Taro Pharmaceutical (TARO)

EPS in 2023 (TTM): $0.99

According to Taro Pharmaceutical's latest financial reports the company's current EPS (TTM) is $1.09. In 2021 the company made an earnings per share (EPS) of $0.07124 an increase over its 2020 EPS that were of -$14.09.

EPS history for Taro Pharmaceutical from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.99
2021$0.07124-100.51%
2020-$14.09-222.45%
2019$11.51-18.02%
2018$14.0353.01%
2017$9.17-55.95%
2016$20.82-13.41%
2015$24.0436.92%
2014$17.5637.71%
2013$12.7521.15%
2012$10.5344.15%
2011$7.30175.17%
2010$2.65-48.8%
2009$5.18
2005$0.05343-91.89%
2004$0.66-82.55%
2003$3.7835.9%
2002$2.7839.29%
2001$1.99140.86%
2000$0.8369.09%
1999$0.49139.13%
1998$0.2064.29%
1997$0.12-36.36%
1996$0.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.31 204.92%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.24 198.64%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.09 2,209.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$3.56-427.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$6.23 473.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
$6.66 513.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland